Literature DB >> 23093621

Unwinding the von Willebrand factor strings puzzle.

Karen De Ceunynck1, Simon F De Meyer, Karen Vanhoorelbeke.   

Abstract

von Willebrand factor (VWF) is amongst others synthesized by endothelial cells and stored as ultra-large (UL) VWF multimers in Weibel-Palade bodies. Although UL-VWF is proteolysed by ADAMTS13 (a disintegrin-like and metalloprotease domain with thrombospondin type-1 motif, number 13) on secretion from endothelial cells, in vitro experiments in the absence of ADAMTS13 have demonstrated that a proportion of these UL-VWF multimers remain anchored to the activated endothelium. These multimers unravel, bind platelets, and wave in the direction of the flow. These so-called VWF "strings" have also been visualized in vivo, lining the lumen of activated mesenteric veins of Adamts13(-/-) mice. Various studies have demonstrated the extraordinary length of these VWF strings, the availability of their platelet binding and ADAMTS13 cleavage sites, and the possible nature of their endothelial attachment. VWF strings are also capable of tethering leukocytes and parasite-infected red blood cells. However, the majority of studies have been performed in the absence of ADAMTS13, a condition only experienced in thrombotic thrombocytopenic purpura. A normal functional role of VWF strings in healthy persons or in other disease pathologies remains unclear. In this review, we discuss some of the puzzling characteristics of VWF strings, and we debate whether the properties of VWF strings in the absence of ADAMTS13 might be relevant for understanding (patho)physiologic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093621     DOI: 10.1182/blood-2012-07-442285

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

1.  Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.

Authors:  Chi Young Shim; Ya Ni Liu; Tamara Atkinson; Aris Xie; Ted Foster; Brian P Davidson; Mackenzie Treible; Yue Qi; José A López; Adam Munday; Zaverio Ruggeri; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

2.  Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Authors:  Miruna Popa; Sibgha Tahir; Julia Elrod; Su Hwan Kim; Florian Leuschner; Thorsten Kessler; Peter Bugert; Ulrich Pohl; Andreas H Wagner; Markus Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-23       Impact factor: 11.205

3.  Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor-binding protein.

Authors:  Jorien Claes; Thomas Vanassche; Marijke Peetermans; Laurens Liesenborghs; Christophe Vandenbriele; Karen Vanhoorelbeke; Dominique Missiakas; Olaf Schneewind; Marc F Hoylaerts; Ruth Heying; Peter Verhamme
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

Review 4.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

Review 5.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

6.  The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium.

Authors:  Thejaswi Kalagara; Tracy Moutsis; Yi Yang; Karin I Pappelbaum; Anne Farken; Lucia Cladder-Micus; Sabine Vidal-Y-Sy; Axel John; Alexander T Bauer; Bruno M Moerschbacher; Stefan W Schneider; Christian Gorzelanny
Journal:  Blood Adv       Date:  2018-09-25

7.  von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans.

Authors:  Alexander T Bauer; Jan Suckau; Kathrin Frank; Anna Desch; Lukas Goertz; Andreas H Wagner; Markus Hecker; Tobias Goerge; Ludmila Umansky; Philipp Beckhove; Jochen Utikal; Christian Gorzelanny; Nancy Diaz-Valdes; Viktor Umansky; Stefan W Schneider
Journal:  Blood       Date:  2015-02-24       Impact factor: 22.113

8.  Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.

Authors:  Gönül Gurol; Ihsan Hakkı Ciftci; Halil Harman; Engin Karakece; Ayhan Kamanli; Ibrahim Tekeoglu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

9.  Von Willebrand factor protects against acute CCl4-induced hepatotoxicity through phospho-p38 MAPK signaling pathway inhibition.

Authors:  Hai-Jian Sun; Jian Chen; Hao Zhang; Bing Ni; Jennifer C van Velkinburgh; Yao Liu; Yu-Zhang Wu; Xia Yang
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

10.  Internal Tensile Force and A2 Domain Unfolding of von Willebrand Factor Multimers in Shear Flow.

Authors:  Michael Morabito; Chuqiao Dong; Wei Wei; Xuanhong Cheng; Xiaohui F Zhang; Alparslan Oztekin; Edmund Webb
Journal:  Biophys J       Date:  2018-09-13       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.